top of page

Neosoma Brain Mets

FDA Cleared and fully-integrated with Neosoma's proprietary cloud platform, with novel mets-specific interfaces, reports, and capabilities, Neosoma Brain Mets is a new paradigm in the efficient assessment and auto-contouring of metastatic brain lesions for the entire multidisciplinary team.

Let's Talk

Please take a moment to fill out the form and we'll get in touch ASAP.

Thanks for submitting!

* Footnotes:​

  • Study processing times based on internal Neosoma benchmarks.

  • Algorithm performance data from retrospective FDA performance testing, to be published.

bottom of page